These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 11409123

  • 1. Variations in glucocorticoid induced osteoporosis prevention in a managed care cohort.
    Mudano A, Allison J, Hill J, Rothermel T, Saag K.
    J Rheumatol; 2001 Jun; 28(6):1298-305. PubMed ID: 11409123
    [Abstract] [Full Text] [Related]

  • 2. Trends in prevention of glucocorticoid-induced osteoporosis.
    Saag KG, Gehlbach SH, Curtis JR, Youket TE, Worley K, Lange JL.
    J Rheumatol; 2006 Aug; 33(8):1651-7. PubMed ID: 16845707
    [Abstract] [Full Text] [Related]

  • 3. Challenges in improving the quality of osteoporosis care for long-term glucocorticoid users: a prospective randomized trial.
    Curtis JR, Westfall AO, Allison J, Becker A, Melton ME, Freeman A, Kiefe CI, MacArthur M, Ockershausen T, Stewart E, Weissman N, Saag KG.
    Arch Intern Med; 2007 Mar 26; 167(6):591-6. PubMed ID: 17389291
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: rates and predictors of care in an academic rheumatology practice.
    Solomon DH, Katz JN, Jacobs JP, La Tourette AM, Coblyn J.
    Arthritis Rheum; 2002 Dec 26; 46(12):3136-42. PubMed ID: 12483716
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Trends and determinants of antiresorptive drug use for osteoporosis among elderly women.
    Perreault S, Dragomir A, Desgagné A, Blais L, Rossignol M, Blouin J, Moride Y, Ste-Marie LG, Fernandès JC.
    Pharmacoepidemiol Drug Saf; 2005 Oct 26; 14(10):685-95. PubMed ID: 15645517
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Population-based hepatitis C surveillance and treatment in a national managed care organization.
    Shatin D, Schech SD, Patel K, McHutchison JG.
    Am J Manag Care; 2004 Apr 26; 10(4):250-6. PubMed ID: 15124501
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prescribing for osteoporosis following the use of inhaled and oral glucocorticoids in general practice.
    Williams D, Bennett K, Feely J.
    Br J Clin Pharmacol; 2004 Dec 26; 58(6):665-72. PubMed ID: 15563364
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.